Innate Pharma S.A. (IPHA)

1.97

0.03 (1.55%)

At close: Apr 17, 2025, 3:51 PM

Innate Pharma S.A. Cash Flow Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-7.57M	-58.1M	-52.81M	-63.98M	-20.76M	3.05M	-48.38M	12.64M
Depreciation & Amortization	5.09M	45.41M	4.6M	56.8M	16.53M	7.4M	4.39M	3.26M
Stock-Based Compensation	4.26M	4.25M	2.62M	2.48M	3.83M	2.71M	9.83M	1.03M
Other Working Capital	-28.2M	-636K	-6.06M	-45.14M	38.86M	-47.1M	-16.98M	-58.68M
Other Non-Cash Items	-2.24M	1.8M	-1.29M	-544K	-774K	253K	-88K	-383K
Deferred Income Tax	n/a	n/a	-1.68M	2.65M	-4.14M	1.16M	3.17M	-2.61M
Change in Working Capital	-32.09M	-12.5M	-9.88M	-49.2M	40.25M	-47.1M	-16.98M	-50.79M
Operating Cash Flow	-32.56M	-19.15M	-58.46M	-51.81M	34.92M	-32.53M	-48.06M	-36.85M
Capital Expenditures	-2.35M	-1.12M	-1.33M	-11.28M	-65.4M	-1.43M	-6.03M	-9.39M
Cash Acquisitions	n/a	n/a	7K	9K	n/a	22K	3.06M	8.04M
Purchase of Investments	n/a	n/a	n/a	-3M	n/a	n/a	-43.27M	-18.15M
Sales Maturities Of Investments	22.77M	3M	n/a	-9K	2M	25.66M	19.84M	88.06M
Other Investing Acitivies	-1.79M	-1K	406K	912K	1.28M	46K	-3.06M	-8.04M
Investing Cash Flow	20.63M	1.88M	-917K	-13.37M	-62.12M	24.28M	-29.46M	60.51M
Debt Repayment	-2.36M	-2.03M	26.63M	-885K	11.92M	-1.34M	537K	-685K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	395K	n/a	188K	-251K	-159K	8K	378K	69K
Financial Cash Flow	-1.97M	-1.83M	26.82M	-1.14M	77.77M	61.22M	915K	-602K
Net Cash Flow	-13.62M	-19.53M	-33.04M	-66.09M	50.57M	52.95M	-76.54M	23.04M
Free Cash Flow	-34.91M	-20.28M	-59.79M	-63.09M	-30.48M	-33.96M	-54.09M	-46.24M